Article
Complement in Lupus: Biomarker, Therapeutic Target, or a Little Bit of Both?
26 Jun 2021
Abstract excerpt
Systemic lupus erythematosus (SLE) is an autoimmune disease with complex pathogenesis involving genetic, hormonal, and environmental factors.1 Mechanistically, evidence shows that dysfunctional apoptotic cell clearance and intracellular autoantigen exposure, together with abnormalities in lymphocyte signaling and interferon production pathways, are key drivers leading to formation of autoantibodies and pathogenic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
